Account
Columbus India wins tele sales process mandate for Max Life Insurance
MUMBAI: Columbus India, the data-driven digital marketing agency from Dentsu Aegis Network, has won the mandate for strategic performance marketing initiatives and tele sales process for Max Life Insurance. The account was won following a direct pitch and will be handled out of the agency’s Gurgaon office.
This engagement will help Max Life Insurance Company deploy a unique "End-to-End Performance model" powering a new growth model for digital customer acquisition.
Speaking on this, Max Life Insurance director and chief operating officer Manik Nangia said, “The unique solution offered by Columbus is in line with our wing to wing customer journey thinking. This model presents a potential to maximise customer opportunity through a data-driven marketing model integrated at the core with a telesales capability – all under one roof. These capabilities are typically absent in the conventional performance marketing setups.”
Columbus India chief business officer Nitin Sabharwal added, “We are extremely excited to take on this role of an end – to – end service provider that will help Max life Insurance reach a larger audience using digital distribution channels, and also achieve cost-effective sustainable revenues using digital marketing platforms.”
Columbus India CEO Anurag Gupta said, “Columbus’ unique digital services framework as a marketing & fulfilment agency helps advertisers remove inefficiencies and focus on productivity. Our call center solution uses state of the art digital communication platforms including cloud telephony and data-driven algorithms to help maximise customer engagement. Our unique solution allows Max life Insurance to work closely with us ensuring revenue focus instead of marketing spends optimisation.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
